Thompson Siegel & Walmsley’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1	Closed	–	–	650
2019 Q4	$0	Sell	1 -70	-99%	-$4.07K	﹤0.01%	791
2019 Q3	$4K	Sell	71 -48,531	-100%	-$2.49M	﹤0.01%	692
2019 Q2	$1.97M	Sell	48,602 -10,410	-18%	-$380K	0.03%	206
2019 Q1	$1.78M	Buy	59,012 +3,840	+7%	+$132K	0.03%	215
2018 Q4	$1.85M	Buy	55,172 +29,685	+116%	+$1.07M	0.03%	207
2018 Q3	$1.07M	Buy	+25,487	New	+$1.01M	0.01%	299
2017 Q4	–	Sell	-66	Closed	-$4K	–	828
2017 Q3	$4K	Sell	66 -196,016	-100%	-$10.2M	﹤0.01%	791
2017 Q2	$9.68M	Sell	196,082 -84,720	-30%	-$3.9M	0.11%	192
2017 Q1	$12.2M	Sell	280,802 -217,661	-44%	-$10.4M	0.14%	177
2016 Q4	$24.4M	Sell	498,463 -95,075	-16%	-$4.4M	0.32%	96
2016 Q3	$28.4M	Sell	593,538 -6,993	-1%	-$345K	0.44%	81
2016 Q2	$32.2M	Sell	600,531 -162,265	-21%	-$7.65M	0.51%	69
2016 Q1	$34.1M	Sell	762,796 -213,704	-22%	-$8.67M	0.55%	68
2015 Q4	$37.3M	Sell	976,500 -102,602	-10%	-$3.92M	0.67%	40
2015 Q3	$34.3M	Buy	1,079,102 +32,349	+3%	+$1.13M	0.64%	46
2015 Q2	$34.6M	Buy	1,046,753 +368,395	+54%	+$13.1M	0.61%	44
2015 Q1	$27.9M	Buy	678,358 +21,328	+3%	+$862K	0.48%	66
2014 Q4	$26.8M	Buy	657,030 +60,788	+10%	+$2.38M	0.51%	60
2014 Q3	$21.9M	Buy	596,242 +332,620	+126%	+$14.4M	0.44%	78
2014 Q2	$12.2M	Buy	263,622 +262,822	+32,853%	+$11.7M	0.24%	180
2014 Q1	$33K	Hold	800	–	–	﹤0.01%	491
2013 Q4	$31K	Hold	800	–	–	﹤0.01%	491
2013 Q3	$19K	Hold	800	–	–	﹤0.01%	521
2013 Q2	$14K	Buy	+800	New	+$11.5K	﹤0.01%	551